NBT Bank’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$264K Sell
2,919
-70
-2% -$6.42K 0.02% 343
2025
Q4
$269K Sell
2,989
-27
-0.9% -$2.56K 0.02% 340
2025
Q3
$297K Sell
3,016
-132
-4% -$13.1K 0.02% 329
2025
Q2
$287K Sell
3,148
-1,434
-31% -$139K 0.02% 330
2025
Q1
$519K Sell
4,582
-874
-16% -$93.5K 0.04% 264
2024
Q4
$576K Sell
5,456
-205
-4% -$22K 0.04% 259
2024
Q3
$611K Sell
5,661
-713
-11% -$77.8K 0.04% 261
2024
Q2
$692K Sell
6,374
-330
-5% -$38.9K 0.05% 245
2024
Q1
$885K Sell
6,704
-122
-2% -$15.2K 0.06% 209
2023
Q4
$831K Buy
6,826
+665
+11% +$74.2K 0.07% 216
2023
Q3
$691K Buy
6,161
+107
+2% +$13.6K 0.07% 192
2023
Q2
$881K Buy
6,054
+70
+1% +$9.51K 0.13% 137
2023
Q1
$773K Sell
5,984
-123
-2% -$15.4K 0.11% 144
2022
Q4
$779K Sell
6,107
-328
-5% -$38.1K 0.11% 142
2022
Q3
$673K Sell
6,435
-198
-3% -$21.7K 0.11% 144
2022
Q2
$697K Buy
6,633
+303
+5% +$35.9K 0.11% 142
2022
Q1
$810K Buy
6,330
+847
+15% +$102K 0.11% 140
2021
Q4
$677K Sell
5,483
-511
-9% -$66.9K 0.09% 151
2021
Q3
$852K Buy
5,994
+490
+9% +$72.1K 0.12% 137
2021
Q2
$859K Sell
5,504
-11
-0.2% -$1.78K 0.12% 137
2021
Q1
$857K Hold
5,515
0.12% 136
2020
Q4
$825K Sell
5,515
-121
-2% -$17.1K 0.13% 136
2020
Q3
$745K Buy
5,636
+633
+13% +$82.7K 0.12% 133
2020
Q2
$580K Buy
5,003
+158
+3% +$18.2K 0.1% 143
2020
Q1
$475K Sell
4,845
-5
-0.1% -$655 0.1% 145
2019
Q4
$705K Buy
4,850
+245
+5% +$33.8K 0.11% 140
2019
Q3
$614K Sell
4,605
-43
-0.9% -$5.55K 0.11% 146
2019
Q2
$532K Buy
4,648
+113
+2% +$13.2K 0.1% 144
2019
Q1
$562K Sell
4,535
-206
-4% -$23.4K 0.1% 141
2018
Q4
$478K Buy
4,741
+579
+14% +$65.1K 0.08% 148
2018
Q3
$531K Sell
4,162
-16
-0.4% -$1.9K 0.09% 145
2018
Q2
$452K Sell
4,178
-334
-7% -$36.4K 0.08% 145
2018
Q1
$478K Sell
4,512
-27
-0.6% -$3.14K 0.08% 147
2017
Q4
$532K Sell
4,539
-372
-8% -$42.1K 0.08% 145
2017
Q3
$558K Sell
4,911
-75
-2% -$8.66K 0.09% 148
2017
Q2
$622K Sell
4,986
-52
-1% -$6.17K 0.1% 143
2017
Q1
$597K Sell
5,038
-114
-2% -$12.9K 0.1% 145
2016
Q4
$516K Buy
5,152
+156
+3% +$16.7K 0.09% 147
2016
Q3
$630K Sell
4,996
-104
-2% -$12.8K 0.11% 134
2016
Q2
$596K Sell
5,100
-51
-1% -$5.77K 0.1% 132
2016
Q1
$533K Sell
5,151
-32
-0.6% -$3.1K 0.09% 136
2015
Q4
$516K Sell
5,183
-123
-2% -$12K 0.09% 136
2015
Q3
$483K Sell
5,306
-8
-0.2% -$802 0.09% 137
2015
Q2
$563K Sell
5,314
-77
-1% -$8.52K 0.09% 133
2015
Q1
$615K Sell
5,391
-167
-3% -$19.1K 0.1% 130
2014
Q4
$612K Sell
5,558
-53
-0.9% -$5.59K 0.1% 131
2014
Q3
$548K Sell
5,611
-101
-2% -$9.93K 0.09% 138
2014
Q2
$576K Sell
5,712
-189
-3% -$18.4K 0.09% 140
2014
Q1
$542K Sell
5,901
-175
-3% -$16.1K 0.08% 143
2013
Q4
$550K Sell
6,076
-154
-2% -$13.3K 0.08% 145
2013
Q3
$497K Sell
6,230
-103
-2% -$8.11K 0.07% 150
2013
Q2
$460K Buy
+6,333
New +$474K 0.07% 148

Other funds holding ZBH

NBT Bank's ZBH Position: Q1 2026 in Review

NBT Bank reduced its Zimmer Biomet (ZBH) stake by 2.3% in Q1 2026, selling an estimated $6.42K and leaving 2,919 shares worth $264K. The position accounts for 0.02% of the portfolio, ranked #343.

NBT Bank first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $885K in Q1 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • NBT Bank held 2,919 shares of Zimmer Biomet worth $264K as of Q1 2026.
  • NBT Bank sold 70 Zimmer Biomet shares in Q1 2026, an estimated $6.42K.
  • Zimmer Biomet made up 0.02% of NBT Bank's portfolio in Q1 2026, its #343 holding.
  • NBT Bank first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • NBT Bank's Zimmer Biomet position peaked at $885K in Q1 2024.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on NBT Bank's 13F filing for Q1 2026, filed 28 Apr 2026.